Are Research Papers Reporting Results from Nutrigenetics Clinical Research a Potential Source of Biohype?

Accountability in Research

Volumn 19, Issue 5, 2012, Pages 285-307

  Stenne, R ^a   Hurlimann, T ^a   Godard, Béatrice ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

nutrigenetics, clinical research, claims, biohype

Indexed keywords

ARTICLE; ETHICS; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL RESEARCH; NUTRIGENOMICS; PUBLISHING; RESEARCH ETHICS;

BIOMEDICAL RESEARCH; ETHICS, RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; NUTRIGENOMICS; PUBLISHING;

EID: 84866858587     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989621.2012.718681     Document Type: Article

References (64)

1. Aronson, N. 1984. "Science as claims-making activity: Implications for social problems research". In Studies in the Sociology of Social Problems, Edited by: Schneider, J. W. and Kitsuse, J. I. 1-30. Norwood, N.J: Ablex.
2. Bateson, W. 1907. Facts limiting the theory of heredity. Science (New York, N.Y.), 26(672): 649-660.
3. Bergmann, M. M., Gorman, U. and Mathers, J. C. 2008. Bioethical considerations for human nutrigenomics. Annual Review of Nutrition, 28: 447-67.
4. Bero, L. A. and Jadad, A. R. 1997. How consumers and policymakers can use systematic reviews for decision making. Annals of Internal Medicine, 127: 37-42.
5. Brown, N. 2003. Hope against hype: Accountability in biopasts, presents and futures. Science Studies, 16: 3-21.
6. Bubela, T. M. and Caulfield, T. A. 2004. Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers. Canadian Medical Association Journal, 170: 1399-1407.
7. Bubela, T., Nisbet, M. C., Borchelt, R., Brunger, F., Critchley, C., Einsiedel, E., Geller, G., Gupta, A., Hampel, J., Hyde-Lay, R., Jandciu, E. W., Jones, S. A., Kolopack, P., Lane, S., Lougheed, T., Nerlich, B., Ogbogu, U., O'Riordan, K., Ouellette, C., Spear, M., Strauss, S., Thavaratnam, T., Willemse, L. and Caulfield, T. 2009. Science communication reconsidered. Nature Biotechnology, 27: 514-518.
8. Bull, C. and Fenech, M. 2008. Genome-health nutrigenomics and nutrigenetics: Nutritional requirements or 'nutriomes' for chromosomal stability and telomere maintenance at the individual level. Proceedings of the Nutrition Society, 67: 146-156.
9. Burstyn, I. and Teschke, K. 1999. Studying the determinants of exposure: A review of methods. American Industrial Hygiene Association Journal, 60: 57-72.
10. Caulfield, T. 2000. Underwhelmed: Hyperbole, regulatory policy, and the genetic revolution. McGill Law Journal. Revue de droit de McGill, 45: 437-460.
11. Caulfield, T. 2004. Biotechnology and the popular press: hype and the selling of science. Trends Biotechnol, 22: 337-339.
12. Caulfield, T. and Condit, C. 2012. Science and the sources of hype. Public Health Genomics, 15: 209-217.
13. Corella, D. 2009. Diet-gene interactions between dietary fat intake and common polymorphisms in determining lipid metabolism. Grasas y aceites, 60: 22-27.
14. Corella, D. and Ordovas, J. M. 2005. Single nucleotide polymorphisms that influence lipid metabolism: Interaction with dietary factors. Annual Review of Nutrition, 25: 341-390.
15. Council, Food Ethics. 2005. Getting personal: Shifting responsabilities for dietary health Brighton: Food Ethics Council
16. Davis, C. D. and Milner, J. 2005. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 570: 305-305.
17. Edelstein, S. 2010. Nutrition in Public Health: A Handbook for Developing Programs and Services, Sudbury, MA: Jones & Bartlett Learning.
18. Eysenbach, G. and Jadad, A. R. 2001. Evidence-based patient choice and consumer health informatics in the Internet age. Journal of medical Internet Research, 3(19)
19. Fleising, U. 2001. In search of genohype: a content analysis of biotechnology company documents. New Genetics and Society, 20: 239-254.
20. Fogg-Johnson, N. and Kaput, J. 2007. Moving forwards with nutrigenomics. Food Technology, 61: 50-61.
21. Fraser, G. E. 2003. A search for truth in dietary epidemiology. American Journal of Clinical Nutrition, 78: 521S-525S.
22. Gilbert, F. and Ovadia, D. 2011. Deep brain stimulation in the media: Over-optimistic portrayals call for a new strategy involving journalists and scientists in ethical debates. Frontiers in Integrative Neuroscience, 5(16)
23. Godard, B. and Hurlimann, T. 2009. Nutrigenomics for global health: Ethical challenges for underserved populations. Current Pharmacogenomics and Personalized Medicine, 7: 205-214.
24. Goldstein, D. B. 2009. Common genetic variation and human traits. New England Journal of Medicine, 360: 1696-1698.
25. Guyatt, G. H., Haynes, R. B., Jaeschke, R. Z., Cook, D. J., Green, L., Naylor, C. D., Wilson, M. C. and Richardson, W. S. 2000. Users' guides to the medical literature: XXV. Evidence-based medicine: Principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 284: 1290-1296.
26. Hartman, J. L. IV. 2006. "Genetic and molecular buffering of phenotypes". In Nutritional Genomics: Discovering the Path to Personalized Nutrition, 105-134. Hoboken, NJ: John Wiley and Sons.
27. Hedgecoe, A. and Martin, P. 2003. The drugs don't work: Expectations and the shaping of pharmacogenetics. Social Studies of Science, 33: 1
28. Helgadottir, A., Manolescu, A., Helgason, A., Thorleifsson, G., Thorsteinsdottir, U., Gudbjartsson, D. F., Gretarsdottir, S., Magnusson, K. P., Gudmundsson, G., Hicks, A., Jonsson, T., Grant, S. F., Sainz, J., O'Brien, S. J., Sveinbjornsdottir, S., Valdimarsson, E. M., Matthiasson, S. E., Levey, A. I., Abramson, J. L., Reilly, M. P., Vaccarino, V., Wolfe, M. L., Gudnason, V., Quyyumi, A. A., Topol, E. J., Rader, D. J., Thorgeirsson, G., Gulcher, J. R., Hakonarson, H., Kong, A. and Stefansson, K. 2006. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nature Genetics, 38: 68-74.
29. Hennekens, C. H., Buring, J. E. and Mayrent, S. L. 1987. Epidemiology in Medicine, Boston, MA: Lippincott Williams and Wilkins.
30. Holtzman, N. A. 1999. Are genetic tests adequately regulated?. Science, 286: 409
31. Hurlimann, T., Stenne, R., Menuz, V. and Godard, B. 2012. Inclusion and exclusion in nutrigenetics clinical research: Ethical and scientific challenges. Journal of Nutrigenetics and Nutrigenomics, 4: 322-344.
32. Ioannidis, J. P. A. 2007. Limitations are not properly acknowledged in the scientific literature. Journal of Clinical Epidemiology, 60: 324-329.
33. Joost, H. G., Gibney, M. J., Cashman, K. D., Gorman, U., Hesketh, J. E., Mueller, M., van Ommen, B., Williams, C. M. and Mathers, J. C. 2007. Personalised nutrition: Status and perspectives. The British Journal of Nutrition, 98: 26-31.
34. LeLorier, J., Gregoire, G., Benhaddad, A., Lapierre, J. and Derderian, F. 1997. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. The New England Journal of Medicine, 337: 536-542.
35. Lomer, M. C. E., Parkes, G. C. and Sanderson, J. D. 2008. Review article: Lactose intolerance in clinical practice-myths and realities. Alimentary Pharmacology and Therapeutics, 27: 93-103.
36. Master, Z. and Resnik, D. 2011. Hype and public trust in science. Science and Engineering Ethics,: 1-15. doi:10.1007/511948-011-9327-6
37. McCabe-Sellers, B., Lovera, D., Nuss, H., Wise, C., Ning, B., Teitel, C., Clark, B. S., Toennessen, T., Green, B., Bogle, M. L. and Kaput, J. 2008. Personalizing nutrigenomics research through community based participatory research and omics technologies. Omics-a, Journal of Integrative Biology, 12: 263-272.
38. McGinn, R. 2010. Ethical responsibilities of nanotechnology researchers: A short guide. NanoEthics, 4: 1-12.
39. Minihane, A. M. 2010. Fatty acid-genotype interactions and cardiovascular risk. Prostaglandins, Leukotrienes and Essential Fatty Acids, 82: 259-264.
40. Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J., Mah, C. and Soumerai, S. B. 2000. Coverage by the news media of the benefits and risks of medications. The New England Journal of Medicine, 342: 1645-1650.
41. Mutch, D. M., Wahli, W. and Williamson, G. 2005. Nutrigenomics and nutrigenetics: The emerging faces of nutrition. FASEB Journal, 19: 1602-1616.
42. National Health Council, Robert Starch Worldwide, Inc. 1997. Americans Talk about Science and Medical News: The National Health Council Report: Prepared For: the National Health Council, Roper Starch.
43. National Institutes of Health. (2012). Office of Extramural Research: Glossary and Acronym List. http://grants.nih.gov/grants/glossary.htm (http://grants.nih.gov/grants/glossary.htm) (Accessed: June 2012).
44. Ordovas, J. M. and Corella, D. 2004a. Nutritional genomics. Annual Review of Genomics and Human Genetics, 5: 71-118.
45. Ordovas, J. M. and Mooser, V. 2004b. Nutrigenomics and nutrigenetics. Current Opinion in Lipidology, 15: 101-108.
46. Penders, B. and Goven, J. 2010. Nutrigenomics and the stewardship of scientific promises. Biotechnology Journal, 5: 909-912.
47. Perez-Martinez, P., Garcia-Rios, A., Delgado-Lista, J., Perez-Jimenez, F. and Lopez-Miranda, J. 2012. Metabolic syndrome: Evidences for a personalized nutrition. Molecular Nutrition and Food Research, 56: 67-76.
48. Rebbeck, T. R., Spitz, M. and Wu, X. F. 2004. Assessing the function of genetic variants in candidate gene association studies. Nature Reviews Genetics, 5: 589-597.
49. Rimbach, G., Boesch-Saadatmandi, C., Frank, J., Fuchs, D., Wenzel, U., Daniel, H., Hall, W. L. and Weinberg, P. D. 2008. Dietary isoflavones in the prevention of cardiovascular disease: A molecular perspective. Food and Chemical Toxicology, 46: 1308-1319.
50. Rinaldi, A. 2012. To hype or not to (o) hype. EMBO Reports, 13: 303-307.
51. Robitaille, J. 2009. Nutrigenomics and personalized diet: What are the anticipated impacts for research on chronic diseases and public health?. Current Pharmacogenomics and Personalized Medicine, 7: 106-114.
52. Roth, F., Lipshitz, H. and Andrews, B. 2009. Q&A: Epistasis. Journal of Biology, 8: 35
53. Rutishauser, I. H. E. 2005. Dietary intake measurements. Public Health Nutrition, 8: 1100-1107.
54. Saukko, P. M., Reed, M., Britten, N. and Hogarth, S. 2010. Negotiating the boundary between medicine and consumer culture: online marketing of nutrigenetic tests. Social Science and Medicine, 70: 744-753.
55. Smith, C. E. and Ordovas, J. M. 2010. Fatty acid interactions with genetic polymorphisms for cardiovascular disease. Current Opinion in Clinical Nutrition and Metabolic Care, 13: 139-144.
56. Suarez-Kurtz, G., Genro, J. P., de Moraes, M. O., Ojopi, E. B., Pena, S. D. J., Perini, J. A., Ribeiro-dos-Santos, A., Romano-Silva, M. A., Santana, I. and Struchiner, C. J. 2010. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians. The Pharmacogenomics Journal, 10: 1-10.
57. Thompson, F. E. and Subar, A. F. 2008. "Dietary assessment methodology". In Nutrition in the Prevention and Treatment of Disease, 3-22. San Diego, CA: Academic Press.
58. Tucker, K. L. 2007. Assessment of usual dietary intake in population studies of gene-diet interaction. Nutrition Metabolism and Cardiovascular Diseases, 17: 74-81.
59. United States Government Accountability Office (GAO). Nutrigenetic Testing: Tests Purchased from Four Web Sites Mislead Consumers. http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:d06977t.pdf (http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:d06977t.pdf)
60. Villagra, D., Duconge, J., Windemuth, A., Cadilla, C. L., Kocherla, M., Gorowski, K., Bogaard, K., Renta, J. Y., Cruz, I. A., Mirabal, S., Seip, R. L. and Ruano, G. 2010. CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies. Clinica Chimica Acta, 411: 1306-1311.
61. Virgili, F. and Perozzi, G. 2008. How does nutrigenomics impact human health?. IUBMB Life, 60: 341-344.
62. Welch, R. B. 2011. Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. British Journal of Nutrition, 106: S3-S15.
63. Welt, F. G. and Losordo, D. W. 2006. Cell therapy for acute myocardial infarction: Curb your enthusiasm?. Circulation, 113: 1272-1274.
64. Williams-Jones, B. and Corrigan, O. P. 2003. Rhetoric and hype: Where's the 'ethics' in pharmacogenomics?. American Journal of Pharmacogenomics, 3: 375-383.